BG

Bellevue Group Portfolio holdings

AUM $4.54B
1-Year Est. Return 22.5%
This Quarter Est. Return
1 Year Est. Return
+22.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.97B
AUM Growth
-$106M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
187
New
Increased
Reduced
Closed

Top Buys

1
+$25.6M
2
+$24.6M
3
+$12.1M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$12M
5
CRL icon
Charles River Laboratories
CRL
+$6.28M

Top Sells

1
+$91.2M
2
+$42.4M
3
+$26.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$20.3M
5
AXSM icon
Axsome Therapeutics
AXSM
+$14.3M

Sector Composition

1 Healthcare 99.34%
2 Industrials 0.59%
3 Energy 0.02%
4 Communication Services 0.01%
5 Technology 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$419M 6.01%
9,463,400
-313,128
2
$335M 4.81%
1,158,126
-18,010
3
$332M 4.76%
919,346
-14,457
4
$303M 4.35%
2,855,146
+10,841
5
$192M 2.75%
956,762
-101,424
6
$184M 2.65%
1,559,801
-17,550
7
$183M 2.62%
2,744,277
-29,100
8
$168M 2.42%
898,092
-11,256
9
$155M 2.22%
3,329,279
-20,100
10
$154M 2.22%
2,193,200
-120,652
11
$152M 2.18%
1,569,851
-3,956
12
$150M 2.15%
296,754
-5,290
13
$147M 2.11%
3,804,047
-46,124
14
$116M 1.67%
2,970,678
-2,500
15
$115M 1.65%
4,058,792
-4,000
16
$110M 1.58%
823,839
-94,068
17
$106M 1.52%
5,912,639
-7,000
18
$97.5M 1.4%
2,190,762
+66,486
19
$96.6M 1.39%
476,932
-702
20
$94.9M 1.36%
414,467
+3,834
21
$94.1M 1.35%
4,204,820
+172,558
22
$92.3M 1.32%
4,680,162
+1,296,900
23
$92M 1.32%
202,492
-6,008
24
$85.8M 1.23%
373,953
-12,382
25
$84.8M 1.22%
1,025,715
+15,088
1
2 3 4 5